Top

Clinical Research in Cardiology

Published in:

01-06-2017 | Letter to the Editors

Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging

Authors: Kristina Dahlem, Guido Michels, Carsten Kobe, Alexander C. Bunck, Henrik ten Freyhaus, Roman Pfister

Published in: Clinical Research in Cardiology | Issue 6/2017

Excerpt

Sirs: …

Phelan D, Collier P, Thavendiranathan P, Popovic ZB, Hanna M, Plana JC, Marwick TH, Thomas JD (2012) Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart 98(19):1442–1448. doi:10.1136/heartjnl-2012-302353 CrossRefPubMed

Gertz MA, Benson MD, Dyck PJ, Grogan M, Coelho T, Cruz M, Berk JL, Plante-Bordeneuve V, Schmidt HH, Merlini G (2015) Diagnosis, prognosis, and therapy of transthyretin amyloidosis. J Am Coll Cardiol 66(21):2451–2466. doi:10.1016/j.jacc.2015.09.075 CrossRefPubMed

Mohty D, Pradel S, Magne J, Fadel B, Boulogne C, Petitalot V, Raboukhi S, Darodes N, Damy T, Aboyans V, Jaccard A (2016) Prevalence and prognostic impact of left-sided valve thickening in systemic light-chain amyloidosis. Clin Res Cardiol. doi:10.1007/s00392-016-1058-x PubMed

aus dem Siepen F, Buss SJ, Andre F, Seitz S, Giannitsis E, Steen H, Katus HA, Kristen AV (2015) Extracellular remodeling in patients with wild-type amyloidosis consuming epigallocatechin-3-gallate: preliminary results of T1 mapping by cardiac magnetic resonance imaging in a small single center study. Clin Res Cardiol 104(8):640–647. doi:10.1007/s00392-015-0826-3 CrossRefPubMed

Kristen AV, Rinn J, Hegenbart U, Lindenmaier D, Merkle C, Rocken C, Hardt S, Giannitsis E, Katus HA (2015) Improvement of risk assessment in systemic light-chain amyloidosis using human placental growth factor. Clin Res Cardiol 104(3):250–257. doi:10.1007/s00392-014-0779-y CrossRefPubMed

Glaudemans AW, van Rheenen RW, van den Berg MP, Noordzij W, Koole M, Blokzijl H, Dierckx RA, Slart RH, Hazenberg BP (2014) Bone scintigraphy with (99 m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis. Amyloid 21(1):35–44. doi:10.3109/13506129.2013.871250 CrossRefPubMed

Mohammed SF, Mirzoyev SA, Edwards WD, Dogan A, Grogan DR, Dunlay SM, Roger VL, Gertz MA, Dispenzieri A, Zeldenrust SR, Redfield MM (2014) Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction. JACC Heart Fail 2(2):113–122. doi:10.1016/j.jchf.2013.11.004 CrossRefPubMedPubMedCentral

Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, Wechalekar AD, Berk JL, Quarta CC, Grogan M, Lachmann HJ, Bokhari S, Castano A, Dorbala S, Johnson GB, Glaudemans AW, Rezk T, Fontana M, Palladini G, Milani P, Guidalotti PL, Flatman K, Lane T, Vonberg FW, Whelan CJ, Moon JC, Ruberg FL, Miller EJ, Hutt DF, Hazenberg BP, Rapezzi C, Hawkins PN (2016) Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 133(24):2404–2412. doi:10.1161/CIRCULATIONAHA.116.021612 CrossRefPubMed

Title: Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging
Authors: Kristina Dahlem
Guido Michels
Carsten Kobe
Alexander C. Bunck
Henrik ten Freyhaus
Roman Pfister
Publication date: 01-06-2017
Publisher: Springer Berlin Heidelberg
Published in: Clinical Research in Cardiology / Issue 6/2017
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-017-1092-3

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2017

Fatal myocardial infarction due to pseudo aneurysm of the aortic annulus after TAVR

Short QT syndrome in pediatrics

Impact of multi-vessel versus single-vessel disease on outcomes after percutaneous coronary interventions for chronic total occlusions

Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial

Synergic impact of oral anticoagulation control and renal function in determining major adverse events in atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the AFCAS registry

Trends in aortic valve replacement in Germany in 2015: transcatheter versus isolated surgical aortic valve repair

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page